MarketPeel
Insider Trading Intelligence
Pricing
…
JF

Jeffrey S. Farrow

TARS
SEE REMARKS · TARSUS PHARMACEUTICALS, INC. · CIK 0001405253
FILING MIX · LIFETIME48%/52%
BUYS
14
SELLS
15
TOTAL VALUE
$2.33M
COMPANIES
2
ACTIVE SINCE
Apr 2023
HOLDINGS NOW
104,051
AVG SELL PX
$47.99
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Jeffrey S. Farrow, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+37.50%+0.56%-0.04%+0.61%+1.64%—
14d8+12.50%+2.51%-0.69%+3.19%+3.96%—
30d8+62.50%+0.74%+0.80%-0.05%-0.64%—
60d8+87.50%-1.22%+7.68%-8.90%-14.85%—
90d8+75.00%-4.43%+8.92%-13.35%-22.22%—
180d8(3 pending)+0.00%+40.53%+15.47%+25.06%-10.75%—
1y8(3 pending)+0.00%+43.31%+17.17%+26.14%+28.66%—
2y8(7 pending)+0.00%+122.87%+35.09%+87.78%+87.78%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 56,801 shares · as of Jun 16, 2026
040,84981,699122,548163,397202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 15 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
14,396$60.95$877.4K56,801Jun 16, 2026Jun 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
27,881——27,882Jun 15, 2026Jun 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
See Remarks
27,881——71,197Jun 15, 2026Jun 17, 2026 ↗View →
ACHV
ACHIEVE LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
47,250——47,250May 29, 2026Jun 2, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
2,186$67.00$146.5K43,316Mar 19, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
2,133$68.71$146.6K45,502Mar 18, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
2,111$69.42$146.5K47,635Mar 17, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
8,020——16,040Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
5,022——15,067Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
See Remarks
13,042——49,746Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,306——19,306Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,724——30,724Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
13,608$40.42$550.0K36,704Jun 17, 2025Jun 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
See Remarks
27,881——50,312Jun 16, 2025Jun 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
27,881——55,763Jun 16, 2025Jun 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
1,186$50.11$59.4K22,431Mar 20, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
1,254$47.40$59.4K23,617Mar 19, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
1,284$46.29$59.4K24,871Mar 18, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
8,019——24,060Mar 17, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
See Remarks
8,019——26,155Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,089——20,089Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,628——30,628Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
10,445$27.47$286.9K18,136Jun 18, 2024Jun 20, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
See Remarks
27,881——28,581Jun 17, 2024Jun 20, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
See Remarks
27,881——83,644Jun 17, 2024Jun 20, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,079——32,079Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
47,500——47,500Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
163,397——163,397Apr 24, 2023Apr 26, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
111,525——111,525Apr 24, 2023Apr 26, 2023 ↗View →
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001405253
ROLE
See Remarks
PRIMARY
TARS
COMPANIES
2
ACTIVE SINCE
Apr 2023
MARKETPEEL · /INSIDER/0001405253DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback